Guidance for industry : postmarketing adverse event reporting for medical products and dietary supplements during an influenza pandemic.

Format:

Book

Government document

Contributor:

United States. Food and Drug Administration. Office of Counterterrorism and Emerging Threats

Center for Drug Evaluation and Research (U.S.)

Center for Biologics Evaluation and Research (U.S.)

Center for Devices and Radiological Health (U.S.)

Center for Food Safety and Applied Nutrition (U.S.)

Language:

English

Subjects (All):

Drugs--Side effects--Reporting--Government policy--United States.

Drugs.

Dietary supplements--Government policy--United States.

Dietary supplements.

Influenza.

Influenza, Human.

Dietary supplements--Government policy.

United States.

Medical Subjects:

Influenza, Human.

Physical Description:

1 online resource (12 pages)

Other Title:

Postmarketing adverse event reporting for medical products and dietary supplements during an influenza pandemic

Place of Publication:

Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Office of Counterterrorism and Emerging Threats : Center for Drug Evaluation and Research : Center for Biologics Evaluation and Research : Center for Devices and Radiological Health : Center for Food Safety and Applied Nutrition, [2008]

Notes:

"Draft guidance."

"Procedural."

"December 2008."

OCLC:

421097512